Heart in Anderson-Fabry disease and other lysosomal storage disorders

被引：175
作者：
Linhart, Ales
Elliott, Perry M.
机构：
[1] UCL, Heart Hosp, London W1G 8PH, England
[2] Charles Univ Prague, Sch Med 1, Prague, Czech Republic
来源：
HEART | 2007年 / 93卷 / 04期
关键词：
D O I：
10.1136/hrt.2005.063818
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：528 / 535
页数：8
相关论文
共 20 条
[1]   Glycogen storage diseases presenting as hypertrophic cardiomyopathy [J].
Arad, M ;
Maron, BJ ;
Gorham, JM ;
Johnson, WH ;
Saul, JP ;
Perez-Atayde, AR ;
Spirito, P ;
Wright, GB ;
Kanter, RJ ;
Seidman, CE ;
Seidman, JG .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (04) :362-372
[2]   Fabry disease: overall effects of agalsidase alfa treatment [J].
Beck, M ;
Ricci, R ;
Widmer, U ;
Dehout, F ;
de Lorenzo, AG ;
Kampmann, C ;
Linhart, A ;
Sunder-Plassmann, G ;
Houge, G ;
Ramaswami, U ;
Gal, A ;
Mehta, A .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2004, 34 (12) :838-844
[3]   Prevalence of Fabry disease in female patients with late-onset hypertrophic cardiomyopathy [J].
Chimenti, C ;
Pieroni, M ;
Morgante, E ;
Antuzzi, D ;
Russo, A ;
Russo, MA ;
Maseri, A ;
Frustaci, A .
CIRCULATION, 2004, 110 (09) :1047-1053
[4]   Relationship between X-inactivation and clinical involvement in Fabry heterozygotes.: Eleven novel mutations in the α-galactosidase A gene in the Czech and Slovak population [J].
Dobrovolny, R ;
Dvorakova, L ;
Ledvinova, J ;
Magage, S ;
Bultas, J ;
Lubanda, JC ;
Elleder, M ;
Karetova, D ;
Pavlikova, M ;
Hrebicek, M .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2005, 83 (08) :647-654
[5]   Coronary microvascular dysfunction in male patients with Anderson-Fabry disease and the effect of treatment with α galactosidase A [J].
Elliott, PM ;
Kindler, H ;
Shah, JS ;
Sachdev, B ;
Rimoldi, OE ;
Thaman, R ;
Tome, MT ;
McKenna, WJ ;
Lee, P ;
Camici, PG .
HEART, 2006, 92 (03) :357-360
[6]   Safety and efficacy of recombinant human α-galactosidase a replacement therapy in Fabry's disease. [J].
Eng, CM ;
Guffon, N ;
Wilcox, WR ;
Germain, DP ;
Lee, P ;
Waldek, S ;
Caplan, L ;
Linthorst, GE ;
Desnick, RJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (01) :9-16
[7]   Brief report: Improvement in cardiac function in the cardiac variant of Fabry's disease with galactose-infusion therapy. [J].
Frustaci, A ;
Chimenti, C ;
Ricci, R ;
Natale, L ;
Russo, MA ;
Pieroni, M ;
Eng, CM ;
Desnick, RJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (01) :25-32
[8]   Metabolic cardiomyopathies [J].
Guertl, B ;
Noehammer, C ;
Hoefler, G .
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2000, 81 (06) :349-372
[9]   Safety and efficacy of recombinant acid alpha-glucosidase (rhGAA) in patients with classical infantile Pompe disease:: results of a phase II clinical trial [J].
Klinge, L ;
Straub, V ;
Neudorf, U ;
Schaper, J ;
Bosbach, T ;
Görlinger, K ;
Wallot, M ;
Richards, S ;
Voit, T .
NEUROMUSCULAR DISORDERS, 2005, 15 (01) :24-31
[10]   New insights in cardiac structural changes in patients with Fabry's disease [J].
Linhart, A ;
Palecek, T ;
Bultas, J ;
Ferguson, JJ ;
Hrudová, J ;
Karetová, D ;
Zeman, J ;
Ledvinová, J ;
Poupetová, H ;
Elleder, M ;
Aschermann, M .
AMERICAN HEART JOURNAL, 2000, 139 (06) :1101-1108
12